Resplandy G - Search Results

1

Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.

Anderson PJ, Critchley JA, Tomlinson B, Resplandy G. Anderson PJ, et al. Among authors: resplandy g. Br J Clin Pharmacol. 1995 Apr;39(4):361-8. doi: 10.1111/j.1365-2125.1995.tb04463.x. Br J Clin Pharmacol. 1995. PMID: 7640141 Free PMC article.

2

The pharmacokinetics of perindopril in patients with liver cirrhosis.

Thiollet M, Funck-Brentano C, Grangé JD, Midavaine M, Resplandy G, Jaillon P. Thiollet M, et al. Among authors: resplandy g. Br J Clin Pharmacol. 1992 Mar;33(3):326-8. doi: 10.1111/j.1365-2125.1992.tb04045.x. Br J Clin Pharmacol. 1992. PMID: 1576057 Free PMC article.

3

The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.

Sennesael J, Ali A, Sweny P, Vandenburg M, Slovic D, Dratwa M, Resplandy G, Genissel P, Desche P. Sennesael J, et al. Among authors: resplandy g. Br J Clin Pharmacol. 1992 Jan;33(1):93-9. doi: 10.1111/j.1365-2125.1992.tb04006.x. Br J Clin Pharmacol. 1992. PMID: 1311597 Free PMC article.

4

Digoxin pharmacokinetics and perindopril in heart failure patients.

Vandenburg MJ, Stephens JD, Resplandy G, Dews IM, Robinson J, Desche P. Vandenburg MJ, et al. Among authors: resplandy g. J Clin Pharmacol. 1993 Feb;33(2):146-9. doi: 10.1002/j.1552-4604.1993.tb03935.x. J Clin Pharmacol. 1993. PMID: 8440763

5

The effect of haemodialysis on the pharmacokinetics of perindoprilat after long-term perindopril.

Guérin A, Resplandy G, Marchais S, Taillard F, London G. Guérin A, et al. Among authors: resplandy g. Eur J Clin Pharmacol. 1993;44(2):183-7. doi: 10.1007/BF00315478. Eur J Clin Pharmacol. 1993. PMID: 8453964

6

Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial.

Portolés A, Terleira A, Calvo A, Martínez I, Resplandy G. Portolés A, et al. Among authors: resplandy g. J Clin Pharmacol. 2006 Oct;46(10):1188-94. doi: 10.1177/0091270006291623. J Clin Pharmacol. 2006. PMID: 16988208 Clinical Trial.

7

Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.

Portolés A, Calvo A, Terleira A, Laredo L, Resplandy G, Gorostiaga C, Moreno A. Portolés A, et al. Among authors: resplandy g. J Clin Pharmacol. 2006 Oct;46(10):1195-203. doi: 10.1177/0091270006291624. J Clin Pharmacol. 2006. PMID: 16988209 Clinical Trial.

8

Pharmacokinetics of perindopril in high-risk populations.

Resplandy G, Genissel P. Resplandy G, et al. J Cardiovasc Pharmacol. 1991;18 Suppl 7:S9-18. J Cardiovasc Pharmacol. 1991. PMID: 1725203 Review.

9

Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers.

Ragueneau I, Laveille C, Jochemsen R, Resplandy G, Funck-Brentano C, Jaillon P. Ragueneau I, et al. Among authors: resplandy g. Clin Pharmacol Ther. 1998 Aug;64(2):192-203. doi: 10.1016/S0009-9236(98)90153-9. Clin Pharmacol Ther. 1998. PMID: 9728900 Clinical Trial.

10

Specific and high affinity binding of perindoprilat, but not of perindopril to blood ACE.

Bree F, Nguyen P, Urien S, Resplandy G, Tillement JP. Bree F, et al. Among authors: resplandy g. Int J Clin Pharmacol Ther Toxicol. 1992 Sep;30(9):325-30. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1330941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page